US 8,686,032 B2Granted

Enzyme inhibitors

AssigneeChroma Therapeutics Ltd.

InventorsAlan Hornsby Davidson, Sanjay Ratilal Patel, Francesca Ann Mazzei, Stephen John Davies, Alan Hastings Drummond, David Festus Moffat, Kenneth William John Baker, Alistair David Graham Donald

Life of this patent

Estimating the term…

Abstract

Compounds of formula (I) are inhibitors of histone deacetylase activity, and are useful in the treatment of, for example, cancers:

Claims2

Dependent claims

A compound (S)-[4-(7-Hydroxycarbamoyl-heptanoylamino)-benzylamino]-phenyl-acetic acid cyclopentyl ester or a salt or N-oxide thereof.

Dependencies are inferred from the claim text.

Facts

Application: 12/957,829Filed 1 Dec 2010 · continuation
Priority: GB 0509223.45 May 2005
Published: US 2013/0116318 A19 May 2013
Granted: 1 Apr 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification30 codes

A61P 3/00
Drugs for disorders of the metabolism
C07C 237/40
Having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the…:…
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics
A61P 7/00
Drugs for disorders of the blood or the extracellular fluid

Family

PCT/GB2006/001605Parent of this continuation · filed 4 May 2006
US 2013/0116318 A1Pre-grant publication · published 9 May 2013
Application11/918,139Parent of this continuation
US 7,939,666 B2Parent of this continuation
US 2009/0291978 A1Published application
US 8,686,032 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results